Protection from glutamate-induced excitotoxicity by memantine

Annals of Biomedical Engineering

Volumn 40, Issue 5, 2012, Pages 1170-1181

  Kutzing, Melinda K ^a   Luo, Vincent ^a   Firestein, Bonnie L ^a,b  

^a RUTGERS UNIVERSITY   (United States)

^b RUTGERS UNIVERSITY   (United States)

Author keywords

Excitotoxicity; Glutamate; Memantine; Microelectrode array; NMDA receptor antagonist; Traumatic brain injury

Indexed keywords

EXCITOTOXICITY; GLUTAMATE; MEMANTINE; MICROELECTRODE ARRAY; NMDA RECEPTOR; TRAUMATIC BRAIN INJURIES;

AMINO ACIDS; BRAIN; MICROELECTRODES;

SYNCHRONIZATION;

AMINO ACID RECEPTOR BLOCKING AGENT; GLUTAMIC ACID; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROPROTECTIVE AGENT;

ANIMAL; ARTICLE; BRAIN INJURY; DRUG ANTAGONISM; DRUG EFFECT; ELECTROPHYSIOLOGY; METABOLISM; NERVE CELL; PATHOPHYSIOLOGY; RAT;

ANIMALS; BRAIN INJURIES; ELECTROPHYSIOLOGICAL PHENOMENA; EXCITATORY AMINO ACID ANTAGONISTS; GLUTAMIC ACID; MEMANTINE; NEURONS; NEUROPROTECTIVE AGENTS; RATS; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 84862008504     PISSN: 00906964     EISSN: 15739686     Source Type: Journal    
DOI: 10.1007/s10439-011-0494-z     Document Type: Article

References (51)

1. Anitha, M., M. S. Nandhu, T. R. Anju, P. Jes, and C. S. Paulose. Targeting glutamate mediated excitotoxicity in Huntington's disease: neural progenitors and partial glutamate antagonist-memantine. Med. Hypotheses 76:138-140, 2011.
2. Bordji, K., J. Becerril-Ortega, and A. Buisson. Synapses, NMDA receptor activity and neuronal Abeta production in Alzheimer's disease. Rev. Neurosci. 22:285-294, 2011.
3. Caveness, W. F. Epilepsy, a product of trauma in our time. Epilepsia 17:207-215, 1976.
4. Cente, M., S. Mandakova, and P. Filipcik. Memantine prevents sensitivity to excitotoxic cell death of rat cortical neurons expressing human truncated tau protein. Cell. Mol. Neurobiol. 29:945-949, 2009.
5. Chen, H. S., and S. A. Lipton. Mechanism of memantine block of NMDA-activated channels in rat retinal ganglion cells: uncompetitive antagonism. J. Physiol. 499(Pt 1):27-46, 1997. (Pubitemid 27098863)
6. Chen, H. S., and S. A. Lipton. The chemical biology of clinically tolerated NMDA receptor antagonists. J. Neurochem. 97:1611-1626, 2006. (Pubitemid 43873656)
7. Chen, H. S., J. W. Pellegrini, S. K. Aggarwal, S. Z. Lei, S. Warach, F. E. Jensen, and S. A. Lipton. Open-channel block of N-methyl-D-aspartate (NMDA) responses by memantine: therapeutic advantage against NMDA receptor- mediated neurotoxicity. J. Neurosci. 12:4427-4436, 1992.
8. Chen, H. S., Y. F. Wang, P. V. Rayudu, P. Edgecomb, J. C. Neill, M. M. Segal, S. A. Lipton, and F. E. Jensen. Neuroprotective concentrations of the N-methyl-D-aspartate open-channel blocker memantine are effective without cytoplasmic vacuolation following post-ischemic administration and do not block maze learning or long-term potentiation. Neuroscience 86:1121-1132, 1998. (Pubitemid 28318538)
9. Chiappalone, M., A. Vato, L. Berdondini, M. Koudelka-Hep, and S. Martinoia. Network dynamics and synchronous activity in cultured cortical neurons. Int. J. Neural Syst. 17:87-103, 2007. (Pubitemid 46906234)
10. Chiappalone, M., A. Vato, M. B. Tedesco, M. Marcoli, F. Davide, and S. Martinoia. Networks of neurons coupled to microelectrode arrays: a neuronal sensory system for pharmacological applications. Biosens. Bioelectron. 18:627-634, 2003. (Pubitemid 36428652)
11. Choi, D. W. Calcium: still center-stage in hypoxic-ischemic neuronal death. Trends Neurosci. 18:58-60, 1995.
12. Choi, D. W., J. Y. Koh, and S. Peters. Pharmacology of glutamate neurotoxicity in cortical cell culture: attenuation by NMDA antagonists. J. Neurosci. 8:185-196, 1988. (Pubitemid 18038308)
13. Dingledine, R., K. Borges, D. Bowie, and S. F. Traynelis. The glutamate receptor ion channels. Pharmacol. Rev. 51:7-61, 1999. (Pubitemid 29113865)
14. Du, Y., C. P. Chen, C. Y. Tseng, Y. Eisenberg, and B. L. Firestein. Astroglia-mediated effects of uric acid to protect spinal cord neurons from glutamate toxicity. Glia 55:463-472, 2007. (Pubitemid 46383176)
15. Gopal, K. V. Neurotoxic effects of mercury on auditory cortex networks growing on microelectrode arrays: a preliminary analysis. Neurotoxicol. Teratol. 25:69-76, 2003. (Pubitemid 36287504)
16. Hales, C. M., J. D. Rolston, and S. M. Potter. How to culture, record and stimulate neuronal networks on microelectrode arrays (MEAs). J. Vis. Exp. (39):e2056, 2010. doi: 10.3791/2056.
17. Hardingham, G. E., Y. Fukunaga, and H. Bading. Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways. Nat. Neurosci. 5:405-414, 2002. (Pubitemid 34454245)
18. Ikonomidou, C., and L. Turski. Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury? Lancet Neurol. 1:383-386, 2002. (Pubitemid 37159164)
19. Johnson, J. W., and S. E. Kotermanski. Mechanism of action of memantine. Curr. Opin. Pharmacol. 6:61-67, 2006. (Pubitemid 43103820)
20. Kharlamov, E. A., E. Lepsveridze, M. Meparishvili, R. O. Solomonia, B. Lu, E. R. Miller, K. M. Kelly, and Z. Mtchedlishvili. Alterations of GABA(A) and glutamate receptor subunits and heat shock protein in rat hippocampus following traumatic brain injury and in posttraumatic epilepsy. Epilepsy Res. 95:20-34, 2011.
21. Kuszczyk, M., M. Slomka, L. Antkiewicz-Michaluk, E. Salinska, and J. W. Lazarewicz. 1-Methyl-1,2,3,4-tetrahydroisoquinoline and established uncompetitive NMDA receptor antagonists induce tolerance to excitotoxicity. Pharmacol. Rep. 62:1041-1050, 2010.
22. Kutzing, M. K., V. Luo, and B. L. Firestein. Measurement of synchronous activity by microelectrode arrays uncovers differential effects of sublethal and lethal glutamate concentrations on cortical neurons. Ann. Biomed. Eng. 39: 2252-2262, 2011.
23. Leveille, F., F. El Gaamouch, E. Gouix, M. Lecocq, D. Lobner, O. Nicole, and A. Buisson. Neuronal viability is controlled by a functional relation between synaptic and extrasynaptic NMDA receptors. FASEB J. 22:4258-4271, 2008.
24. Li, Y., W. Zhou, X. Li, S. Zeng, M. Liu, and Q. Luo. Characterization of synchronized bursts in cultured hippocampal neuronal networks with learning training on microelectrode arrays. Biosens. Bioelectron. 22:2976-2982, 2007. (Pubitemid 46754870)
25. Lin, C. H., S. H. Juan, C. Y. Wang, Y. Y. Sun, C. M. Chou, S. F. Chang, S. Y. Hu, W. S. Lee, and Y. H. Lee. Neuronal activity enhances aryl hydrocarbon receptor-mediated gene expression and dioxin neurotoxicity in cortical neurons. J. Neurochem. 104:1415-1429, 2008. (Pubitemid 351293349)
26. Lipton, S. A. Prospects for clinically tolerated NMDA antagonists: open-channel blockers and alternative redox states of nitric oxide. Trends Neurosci. 16:527-532, 1993. (Pubitemid 23341962)
27. Lipton, S. A. NMDA receptors, glial cells, and clinical medicine. Neuron 50:9-11, 2006.
28. Lipton, S. A. Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond. Nat. Rev. Drug Discov. 5:160-170, 2006.
29. Lipton, S. A. Pathologically activated therapeutics for neuroprotection. Nat. Rev. Neurosci. 8:803-808, 2007. (Pubitemid 47462118)
30. Lipton, S. A., and P. A. Rosenberg. Excitatory amino acids as a final common pathway for neurologic disorders. N. Engl. J. Med. 330:613-622, 1994.
31. Lowenstein, D. H. Epilepsy after head injury: an overview. Epilepsia 50(Suppl. 2):4-9, 2009.
32. Mayer, M. L., G. L. Westbrook, and P. B. Guthrie. Voltage- dependent block by Mg2+ of NMDA responses in spinal cord neurones. Nature 309:261-263, 1984. (Pubitemid 14139936)
33. Morefield, S. I., E. W. Keefer, K. D. Chapman, and G. W. Gross. Drug evaluations using neuronal networks cultured on microelectrode arrays. Biosens. Bioelectron. 15:383-396, 2000.
34. Nowak, L., P. Bregestovski, P. Ascher, A. Herbet, and A. Prochiantz. Magnesium gates glutamate-activated channels in mouse central neurones. Nature 307:462-465, 1984. (Pubitemid 14132062)
35. Okamoto, S., M. A. Pouladi, M. Talantova, D. Yao, P. Xia, D. E. Ehrnhoefer, R. Zaidi, A. Clemente, M. Kaul, R. K. Graham, D. Zhang, H. S. Vincent Chen, G. Tong, M. R. Hayden, and S. A. Lipton. Balance between synaptic versus extrasynaptic NMDA receptor activity influences inclusions and neurotoxicity of mutant huntingtin. Nat. Med. 15:1407-1413, 2009.
36. Papadia, S., F. X. Soriano, F. Leveille, M. A. Martel, K. A. Dakin, H. H. Hansen, A. Kaindl, M. Sifringer, J. Fowler, V. Stefovska, G. McKenzie, M. Craigon, R. Corriveau, P. Ghazal, K. Horsburgh, B. A. Yankner, D. J. Wyllie, C. Ikonomidou, and G. E. Hardingham. Synaptic NMDA receptor activity boosts intrinsic antioxidant defenses. Nat. Neurosci. 11:476-487, 2008. (Pubitemid 351441886)
37. Rao, V. L., A. Dogan, K. G. Todd, K. K. Bowen, and R. J. Dempsey. Neuroprotection by memantine, a noncompetitive NMDA receptor antagonist after traumatic brain injury in rats. Brain Res. 911:96-100, 2001. (Pubitemid 32728243)
38. Reisberg, B., R. Doody, A. Stoffler, F. Schmitt, S. Ferris, and H. J. Mobius. Memantine in moderate-to-severe Alzheimer's disease. N. Engl. J. Med. 348:1333-1341, 2003. (Pubitemid 36384100)
39. Rogawski, M. A. Therapeutic potential of excitatory amino acid antagonists: channel blockers and 2,3-benzodiazepines. Trends Pharmacol. Sci. 14:325-331, 1993. (Pubitemid 23282161)
40. Rogawski, M. A., and G. L. Wenk. The neuropharmacological basis for the use of memantine in the treatment of Alzheimer's disease. CNS Drug Rev. 9:275-308, 2003. (Pubitemid 37254706)
41. Sattler, R., M. P. Charlton, M. Hafner, and M. Tymianski. Distinct influx pathways, not calcium load, determine neuronal vulnerability to calcium neurotoxicity. J. Neurochem. 71:2349-2364, 1998. (Pubitemid 28531245)
42. Shew, W. L., T. Bellay, and D. Plenz. Simultaneous multielectrode array recording and two-photon calcium imaging of neural activity. J. Neurosci. Methods 192:75-82, 2010.
43. Sihver, S., N. Marklund, L. Hillered, B. Langstrom, Y. Watanabe, and M. Bergstrom. Changes in mACh, NMDA and GABA(A) receptor binding after lateral fluidpercussion injury: in vitro autoradiography of rat brain frozen sections. J. Neurochem. 78:417-423, 2001. (Pubitemid 32729970)
44. Tani, H., A. E. Bandrowski, I. Parada, M. Wynn, J. R. Huguenard, D. A. Prince, and R. J. Reimer. Modulation of epileptiform activity by glutamine and system A transport in a model of post-traumatic epilepsy. Neurobiol. Dis. 25:230-238, 2007. (Pubitemid 46124006)
45. Tariot, P. N., M. R. Farlow, G. T. Grossberg, S. M. Graham, S. McDonald, and I. Gergel. Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial. JAMA 291:317-324, 2004. (Pubitemid 38101604)
46. Wilkinson, D., and H. F. Andersen. Analysis of the effect of memantine in reducing the worsening of clinical symptoms in patients with moderate to severe Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 24:138-145, 2007. (Pubitemid 47094073)
47. Willmore, L. J., and D. H. Lowenstein. Epilepsy and trauma: a persistent challenge. Neurology 75:202-203, 2010.
48. Wrighton, D. C., E. J. Baker, P. E. Chen, and D. J. Wyllie. Mg2+ and memantine block of rat recombinant NMDA receptors containing chimeric NR2A/2D subunits expressed in Xenopus laevis oocytes. J. Physiol. 586:211-225, 2008.
49. Xia, P., H. S. Chen, D. Zhang, and S. A. Lipton. Memantine preferentially blocks extrasynaptic over synaptic NMDA receptor currents in hippocampal autapses. J. Neurosci. 30:11246-11250, 2010.
50. Ye, Z. C., and H. Sontheimer. Astrocytes protect neurons from neurotoxic injury by serum glutamate. Glia 22:237-248, 1998. (Pubitemid 28159015)
51. Zeevalk, G. D., and W. J. Nicklas. Evidence that the loss of the voltage-dependent Mg2+ block at the N-methyl-D-aspartate receptor underlies receptor activation during inhibition of neuronal metabolism. J. Neurochem. 59:1211-1220, 1992.